Skip to Main Content
Our Commitment to Diversity

K&L Gates Assists Sentiss Pharma in Acquisition of Akorn AG Switzerland

1 August 2023

Global law firm K&L Gates LLP recently advised pharmaceutical manufacturing company Sentiss Pharma on the successful acquisition of Akorn AG Switzerland, along with its US FDA-approved sterile manufacturing plant and diverse portfolio of approved products for the US market.

The acquisition allows Sentiss Pharma to expand their capabilities and global market presence, and includes a line of unique, high market demand products and abbreviated new drug applications (ANDAs) that complement the company’s current offerings.

The K&L Gates team that advised Sentiss Pharma on the acquisition was led by New York Corporate partner Jonathan Barron and Raleigh office Restructuring partner Lee Hogewood, and supported by New York associate Arielle Wisotsky.

“We were delighted to participate with Sentiss in a complex and successful bankruptcy auction process that will allow our client to restore the supply of a number of products to the benefit of many US patients, including children with significant respiratory issues,” Hogewood stated. 

K&L Gates is a fully integrated global law firm with lawyers located across five continents. The firm represents leading multinational corporations, growth and middle-market companies, capital markets participants and entrepreneurs in every major industry group as well as public sector entities, educational institutions, philanthropic organizations and individuals.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel